Patent · US Active

Compounds

US10479792B2 · kind B2 · utility

0Cited by
2References
24Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 3, 2016
Grant dateNov 19, 2019
Priority date—
Expiry dateAug 3, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound of Formula (I), or a salt thereof,

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.